|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/30 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| C12N 5/12 |
| (11) | Patento numeris | 2152754 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08758782.0 |
| Europos patento paraiškos padavimo data | 2008-05-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-02-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/004197 |
| Data | 2008-05-27 |
| (87) | Numeris | WO 2008/145338 |
| Data | 2008-12-04 |
| (30) | Numeris | Data | Šalis |
| 07010622 | 2007-05-29 | EP | |
| 932099 P | 2007-05-29 | US |
| (72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
BRANDENBURG, Gunda, DE
USENER, Dirk, DE
|
| (73) |
Astellas Pharma Inc.,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411,
JP
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb, Freiligrathstrasse 12, 55131 Mainz, DE |
| (54) | MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER |
| MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER |